HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recombinant single-chain immunotoxins against T and B cell leukemias.

Abstract
Interleukin 2 (IL2) receptors (IL2R's) are found on malignant cells in many human leukemias and lymphomas and are expressed by activated T cells in many autoimmune disorders. Anti-Tac(Fv), a single-chain protein composed of the variable heavy and light domains of the anti-IL2R monoclonal antibody anti-Tac, can be genetically fused to derivatives of Pseudomonas exotoxin (PE) or diphtheria toxin (DT) to form potent immunotoxins. We have shown that anti-Tac(Fv) binds to low affinity IL2R's on fresh chronic lymphocytic leukemia (CLL) and adult T-cell leukemia (ATL) cells and can target either toxin to kill those cells. Anti-Tac(Fv)-PE40, containing the truncated form of PE without its binding domain, was cytotoxic to malignant cells from 8 of 8 ATL patients tested, with IC50's ranging from 0.11 to 5.5 ng/ml. Anti-Tac(Fv)-PE40KDEL, a derivative of anti-Tac(Fv)-PE40 which contains the KDEL carboxyl terminus, was more cytotoxic toward cells from all ATL patients and also killed CLL cells from 8 of 16 patients. DT388-anti-Tac(Fv), containing amino acids 1-388 of DT fused to the amino terminus of anti-Tac(Fv), was less cytotoxic than anti-Tac(Fv)-PE40 on ATL cells from 4 of 5 patients, but was cytotoxic toward CLL cells from 12 of 16 patients. DT388-IL2, where IL2 is substituted for anti-Tac(Fv), is similar to DAB389IL2, an IL2-toxin currently in clinical trials. DT388-IL2 and DAB389IL2 differ by only a few amino acids and have equal cytotoxic activity. DT388-IL2 was cytotoxic toward ATL cells from all patients tested, but usually required much higher concentrations than anti-Tac(Fv)-PE40 and was poorly active against CLL cells. Thus, recombinant toxins containing anti-Tac(Fv) are cytotoxic toward freshly isolated CLL and ATL cells and will be studied further as potential therapy for IL2R-related disorders.
AuthorsR J Kreitman, I Pastan
JournalLeukemia & lymphoma (Leuk Lymphoma) Vol. 13 Issue 1-2 Pg. 1-10 (Mar 1994) ISSN: 1042-8194 [Print] United States
PMID8025511 (Publication Type: Journal Article, Review)
Chemical References
  • Antibodies, Monoclonal
  • Bacterial Toxins
  • Diphtheria Toxin
  • Exotoxins
  • Immunoglobulin Heavy Chains
  • Immunoglobulin mu-Chains
  • Immunotoxins
  • Receptors, Interleukin-2
  • Recombinant Proteins
  • Virulence Factors
  • ADP Ribose Transferases
  • Pseudomonas aeruginosa exotoxin A
Topics
  • ADP Ribose Transferases
  • Amino Acid Sequence
  • Antibodies, Monoclonal
  • Bacterial Toxins (therapeutic use, toxicity)
  • Cell Survival (drug effects)
  • Diphtheria Toxin (therapeutic use, toxicity)
  • Exotoxins (therapeutic use, toxicity)
  • Humans
  • Immunoglobulin Heavy Chains
  • Immunoglobulin mu-Chains
  • Immunotoxins (biosynthesis, therapeutic use, toxicity)
  • Leukemia, B-Cell (therapy)
  • Leukemia, Lymphocytic, Chronic, B-Cell
  • Leukemia, T-Cell (therapy)
  • Leukemia-Lymphoma, Adult T-Cell
  • Molecular Sequence Data
  • Receptors, Interleukin-2 (immunology)
  • Recombinant Proteins (biosynthesis, therapeutic use, toxicity)
  • Tumor Cells, Cultured
  • Virulence Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: